YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD

Altre lingue Yunnan Botanee Bio-Technology Group Co.LTD

Azioni

300957

CNE100004G74

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 25/04/2024			Variaz. 5gg	Var. 1 gen.
57,51 ^CNY	-0,95%		+1,88%	-15,64%

25/04	Yunnan Botanee Bio-Technology Group Co.LTD riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
25/04	Yunnan Botanee Bio-Technology Group Co.LTD riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Full Year Ended December 31, 2023	25/04
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	01/04
Certain A Shares of Yunnan Botanee Bio-Technology Group Co.LTD are subject to a Lock-Up Agreement Ending on 25-MAR-2024.	25/03
Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD	15/03
Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.	13/03
Tranche Update on Yunnan Botanee Bio-Technology Group Co.LTD's Equity Buyback Plan announced on August 30, 2023.	02/01
In China's slowing beauty market, big brand discounts won't cut it	08/12
Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.	06/12
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback.	27/10/23
Weimai Medical Technology Co., Ltd. announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD	27/10/23
Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares.	30/08/23
Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan.	30/08/23
Yunnan Botanee’s H1 Profit Jumps 14% as Revenue Grows 15.5%	29/08/23
Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Shanghai Ruishi Health Technology Co., Ltd. announced that it has received CNY 100 million in funding from BRV Partners, LLC, Yaojin Private Equity Fund Management Co., Ltd., Sinovation Ventures Enterprise Management Limited, Yunnan Botanee Bio-Technology Group Co.LTD	09/08/23
Yunnan Botanee Seeks to Double Revenue in Three Years	14/07/23
Yunnan Botanee Bio-Technology Group Co.LTD Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 30 May 2023	24/05/23
Yunnan Botanee Bio-Technology Group Co.Ltd Announces Cash Dividend for 2022	18/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Yunnan Botanee Bio-Technology Group Co.LTD

Azioni

300957

CNE100004G74

Altre lingue

Filtri